Item Type | Name |
Academic Article
|
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease.
|
Academic Article
|
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
|
Academic Article
|
Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention.
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
Academic Article
|
BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD.
|
Academic Article
|
Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
|
Academic Article
|
Allogeneic haematopoietic transplantation for Richter's syndrome.
|
Academic Article
|
The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy.
|
Academic Article
|
Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome.
|
Academic Article
|
Allogenic bone marrow transplantation in chronic lymphocytic leukemia.
|
Academic Article
|
High-dose chemotherapy for chronic lymphocytic leukemia: eligibility, timing, and benefit?
|
Academic Article
|
Hematopoietic stem cell transplantation for chronic lymphocytic leukemia.
|
Academic Article
|
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival.
|
Academic Article
|
Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?
|
Academic Article
|
Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.
|
Academic Article
|
Genetically identical twin transplantation for chronic lymphocytic leukemia.
|
Academic Article
|
Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.
|
Academic Article
|
Neutropenias following allogeneic bone marrow transplantation: response to therapy with high-dose intravenous immunoglobulin.
|
Academic Article
|
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
|
Academic Article
|
Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
|
Academic Article
|
Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.
|
Academic Article
|
Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Case report and review.
|
Academic Article
|
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.
|
Academic Article
|
Reduced-intensity regimens in allogeneic stem-cell transplantation for non-hodgkin lymphoma and chronic lymphocytic leukemia.
|
Academic Article
|
The role of stem cell transplantation in the management of chronic lymphocytic leukaemia.
|
Academic Article
|
Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis.
|
Academic Article
|
Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab).
|
Academic Article
|
Radioimmunotherapy in allogeneic nonmyeloablative conditioning for B cell lymphoma: should we use it more often?
|
Academic Article
|
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure.
|
Academic Article
|
Fludarabine (famp)-based chemotherapy at conventional doses allows engraftment of allogeneic (allo) peripheral blood progenitor cell (pbpc) transplantation in chronic lymphocytic leukemia (cll)
|
Academic Article
|
Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion
|
Academic Article
|
Comparable survival for nonablative and ablative allogeneic transplantation for chronic lymphocytic leukemia (CLL)
|
Academic Article
|
Outcomes of Haploidentical Stem Cell Transplantation for?Lymphoma with Melphalan-Based Conditioning.
|
Academic Article
|
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.
|
Academic Article
|
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.
|
Academic Article
|
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors.
|